GlassScriptPhysician profile
Steven K Rowe
NPI 1760575823
$1,042.97
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $110 · 2021: $233.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $389.05 | 2019-2021 | |
| Biotronik INC. | $347.25 | 2019 | |
| Edwards Lifesciences Corporation | $170.84 | 2019 | |
| Amgen INC. | $44.14 | 2019 | |
| Grifols USA, LLC | $20.86 | 2019 | |
| Acist Medical Systems, INC. | $18.00 | 2021 | |
| Medtronic, INC. | $15.57 | 2021 | |
| Medicomp INC | $13.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.47 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $11.23 | 2019 |
4 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Rowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.